Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

What’s Behind Friday’s Roku Stock Jump?

ROKU is firing on all cylinders in the U.S. but the challenge of international expansion looms.

Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study

In the latest Sangamo Therapeutics news, SGMO stock is gaining after the company's hemophilia A gene therapy study yielded positive results.

CannTrust News: Why CTST Stock Is Plunging Today

In recent CannTrust news, CTST stock is down more than 20% on Monday as regulators seized the company's cannabis. Here's what you should know.

Medallia IPO: 7 Things for MDLA Investors to Know

The Medallia IPO is on the horizon, which will see the company's value at $2.2 billion. Here are seven things that investors should know.

Trust Is Clearly Still a Problem for Plug Power Stock

The PLUG stock price has dipped despite good news of late. Investors remain skeptical toward Plug Power stock.

We Can’t Afford to Regulate Facebook Amid the Tech Cold War

With FB and Facebook stock, the underlying assets are simply too crucial for our national interests to risk over secondary issues like online privacy.

Twitter Succeeds Where Apple Stock Falters

Apple attempted to bolster AAPL stock with its news-aggregate membership service, but instead, Twitter is stealing the consumer tech giant's thunder.

Can the Rally of Micron Stock Last?

MU has pulled off an impressive rally. But this may be temporary. MU stock faces some tough headwinds, including chip-sector weakness..

10 Best Stocks for 2019: A Volatile First Half

At the halfway point of the Best Stocks for 2019 contest, three tech companies and a pot stock are battling for second while a retailer sits happily in first.

Where Is Canopy Growth Stock Headed After the Shocking Removal of Its Co-CEO?

CGC stock has lost steam during the past few months. A big issue is the disappointing quarterly report. But Canopy Growth stock should rebound.

Target Stock Can Clear $100 — But Mind the Risks

Omnichannel efforts have driven TGT stock higher. More of the same -- if the situation holds -- can get Target stock to $100 and beyond.

Now May Not Be the Time to Buy Alibaba Stock

BABA stock could see downward pressure in the second half of 2019. Given that the trade war is far from over, there may be a better opportunity down the road.

When Will It Be Safe to Buy Uber Stock?

For Uber stock to become a buy, the stock needs to get above and stay above the $45 IPO price. Below it and Uber remains too choppy.

It’ll Take Some Work, But AMD Stock Can Move Higher

AMD may take market share from Intel over the next several years, boosting AMD stock, That is one of several potential tailwinds that could buoy Advanced Micro Devices stock.

Apple Stock or Microsoft Stock: Which Should Investors Buy Now?

Microsoft and Apple are twin children of different mothers. Today MSFT lives inside other products through its cloud, while AAPL dominates as a brand with its devices.

Twilio Stock Has Become a ‘Hold’ for This Type of Investor

Although I don't see Twilio stock as one to buy right now, this type of investor could make a case for staying with TWLO.

Blue Bell Ice Cream Licker Faces 20 Years in Prison

The Blue Bell ice cream licker may see 20 years behind bars for going to a grocery store, licking ice cream and returning it as if it was new.

EV News: A Jaguar Electric Sedan Is Next Up for the Auto Maker

A Jaguar electric sedan is the latest in EV news as part of the company's $1.25 billion remaking of its UK manufacturing plant focused on EVs.

Tyme Technologies News: Why TYME Stock Is Rocketing

In the latest Tyme Technologies news, TYME stock is up over 20% following a positive data regarding the company's pancreatic cancer treatment.